These discrepancies between our results and those of Tsukui may be explained by the use of different antibodies and the immunohistochemical reaction conditions used to examine the expression of DKK4, the small number of enrolled patients, and the heterogeneous genetic background of CRC. This evidence concerns the gene DKK4 and colorectal carcinoma.